Unknown

Dataset Information

0

Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile.


ABSTRACT: Clostridioides difficile is a leading health threat. This pathogen initiates intestinal infections during gut microbiota dysbiosis caused by oral administration of antibiotics. C. difficile is difficult to eradicate due to its ability to form spores, which are not susceptible to antibiotics. To address the urgent need for treating recurrent C. difficile infection, antibiotics that selectively target C. difficile over common gut microbiota are needed. We herein describe the class of picolinamide antibacterials which show potent and selective activity against C. difficile. The structure-activity relationship of 108 analogues of isonicotinamide 4, a compound that is equally active against methicillin-resistant Staphylococcus aureus and C. difficile, was investigated. Introduction of the picolinamide core as exemplified by analogue 87 resulted in exquisite potency and selectivity against C. difficile. The ability of the picolinamide class to selectively target C. difficile and to prevent gut dysbiosis holds promise for the treatment of recurrent C. difficile infection.

SUBMITTER: Speri E 

PROVIDER: S-EPMC8201750 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target <i>Clostridioides difficile</i>.

Speri Enrico E   Qian Yuanyuan Y   Janardhanan Jeshina J   Masitas Cesar C   Lastochkin Elena E   De Benedetti Stefania S   Wang Man M   Schroeder Valerie A VA   Wolter William R WR   Oliver Allen G AG   Fisher Jed F JF   Mobashery Shahriar S   Chang Mayland M  

ACS medicinal chemistry letters 20210507 6


<i>Clostridioides difficile</i> is a leading health threat. This pathogen initiates intestinal infections during gut microbiota dysbiosis caused by oral administration of antibiotics. <i>C. difficile</i> is difficult to eradicate due to its ability to form spores, which are not susceptible to antibiotics. To address the urgent need for treating recurrent <i>C. difficile</i> infection, antibiotics that selectively target <i>C. difficile</i> over common gut microbiota are needed. We herein describ  ...[more]

Similar Datasets

| S-EPMC7716698 | biostudies-literature
| S-EPMC4885108 | biostudies-literature
| S-EPMC7073871 | biostudies-literature
| S-EPMC6589130 | biostudies-literature
| S-EPMC6009985 | biostudies-literature
2022-04-09 | GSE200346 | GEO
| S-EPMC8924006 | biostudies-literature
| S-EPMC8728606 | biostudies-literature
2022-09-17 | GSE165751 | GEO
2019-01-15 | GSE120189 | GEO